These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity. Matriano JA, Socarras S, Streilein JW. J Immunol; 1994 Aug 15; 153(4):1505-14. PubMed ID: 7913940 [Abstract] [Full Text] [Related]
3. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced. Matriano JA, Socarras S, Streilein JW. J Immunol; 1994 Aug 15; 153(4):1515-26. PubMed ID: 8046230 [Abstract] [Full Text] [Related]
4. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes. Mohler KM, Streilein JW. J Immunol; 1987 Oct 01; 139(7):2211-9. PubMed ID: 2958541 [Abstract] [Full Text] [Related]
5. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K. J Immunol; 1990 Dec 15; 145(12):4026-36. PubMed ID: 2147933 [Abstract] [Full Text] [Related]
6. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. Powell TJ, Streilein JW. J Immunol; 1990 Feb 01; 144(3):854-9. PubMed ID: 2136901 [Abstract] [Full Text] [Related]
7. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules. Kramar G, Schurmans S, Berney M, Izui S, del Giudice G, Lambert PH. J Autoimmun; 1995 Apr 01; 8(2):177-92. PubMed ID: 7612147 [Abstract] [Full Text] [Related]
9. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H. J Immunol; 1989 Sep 01; 143(5):1447-52. PubMed ID: 2527264 [Abstract] [Full Text] [Related]
10. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification. Wood PJ, Strome PG, Streilein JW. J Immunol; 1987 Jun 01; 138(11):3661-8. PubMed ID: 2884256 [Abstract] [Full Text] [Related]
11. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR, Perry LL. J Immunol; 1985 May 01; 134(5):2942-7. PubMed ID: 3156920 [Abstract] [Full Text] [Related]
12. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen. Maeda H, Ogoshi S, Fujimoto S. Transplant Proc; 1994 Apr 01; 26(2):847-8. PubMed ID: 8171685 [No Abstract] [Full Text] [Related]
13. Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens. Levy RB, Jones M, Streilein JW. Transplant Proc; 1993 Feb 01; 25(1 Pt 1):360-1. PubMed ID: 8438335 [No Abstract] [Full Text] [Related]
14. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors. Chow KP, Battisto JR. J Immunol; 1988 Feb 15; 140(4):1005-13. PubMed ID: 2963857 [Abstract] [Full Text] [Related]
15. Differential susceptibility of cytotoxic and helper T cell precursors to neonatal tolerization to histocompatibility antigens. Ishizaka ST, Carnaud C, Stutman O. J Immunol; 1986 Oct 01; 137(7):2093-9. PubMed ID: 2944947 [Abstract] [Full Text] [Related]
16. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL. McCarthy SA, Singer A. J Immunol; 1986 Nov 15; 137(10):3087-92. PubMed ID: 3095422 [Abstract] [Full Text] [Related]
17. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells. Ramos A, Merino R, Merino J. Immunology; 1994 Jun 15; 82(2):287-93. PubMed ID: 7927500 [Abstract] [Full Text] [Related]
18. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens. Tomita Y, Mayumi H, Eto M, Nomoto K. J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930 [Abstract] [Full Text] [Related]
19. Modification of the cytotoxic T cell repertoire in neonatal tolerance. Evidence for preferential survival of cells with low avidity for tolerogen. Wood PJ, Socarras S, Streilein JW. J Immunol; 1987 Nov 15; 139(10):3236-44. PubMed ID: 3316382 [Abstract] [Full Text] [Related]
20. Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice. Biasi G, Saggin L, Dazzi F, Collavo D. Transplant Proc; 1983 Dec 15; 15(4):2125-7. PubMed ID: 6608813 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]